Top Markets
#1 QuantixAI QuantixAI +34.75%
#2 Siren Siren +30.13%
#3 MowCat MowCat +27.45%
#4 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +24.55%
#5 Prom Prom +23.43%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +18.49%
#7 UnifAI Network UnifAI Network +18.36%
#8 Versatize Coin Versatize Coin +16.67%
#9 Pons Pons +15.01%
#10 Tutorial Tutorial +14.17%
Coin of the day
QuantixAI QuantixAI
Ρυθμίσεις
Γλώσσα
Ελληνικά
Νόμισμα
USD
Θέμα
Sunho Biologics, Inc. Sunho Biologics, Inc.

Sunho Biologics, Inc.

2898
Κατάταξη σε μετοχές #20675
Sunho Biologics, Inc. is a biopharmaceutical firm dedicated to discovering,... Sunho Biologics, Inc. is a biopharmaceutical firm dedicated to discovering, advancing, and bringing to market biological therapies. These treatments are designed to influence the body's immune system, both its inherent and adaptive responses, thereby altering the immune microenvironment. Among its portfolio is IAH0968, a monoclonal antibody specifically engineered to enhance antibody-dependent cell-mediated cytotoxicity, currently undergoing Phase II clinical trials for the treatment of biliary tract carcinoma and colorectal cancer. The company also develops IAP0971 and IAE0972, a pair of immunocytokines that have successfully concluded Phase I clinical trials for various advanced solid tumors, notably non-small cell lung cancer and colorectal cancer. Sunho Biologics also boasts a robust pipeline of early-stage assets. These include IBB0979, an immunocytokine targeting solid tumors; IBC0966, a dual-action fusion protein (anti-PD-L1 antibody-signal regulatory protein) in clinical development, designed to elicit tumor-specific immune responses; IBD0333, aimed at tumor cells; IAN0982, another oncology candidate; and immunosuppressants ISH0988 and ISH0613, which are being explored for autoimmune conditions. Established in 2018, the company operates from its headquarters in Huzhou, China, and functions as a subsidiary of Sunho Wisdom Investments Limited.
Τιμή μετοχής
$0.81744861
Τελευταίος συγχρονισμός: 2026-04-02
Κεφαλαιοποίηση
$124.61M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
-7.82%
Χώρα
CN
Εμπόριο Sunho Biologics, Inc. (2898)

Κατηγορία

Healthcare
Ιστορικό μερισμάτων για Sunho Biologics, Inc. (2898)
Η μετοχή Sunho Biologics, Inc. (σύμβολο: 2898) κατέβαλε συνολικά 0 μερίσματα.
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: 0.00
Απόδοση μερίσματος (TTM): 0
Καταβολές μερισμάτων για Sunho Biologics, Inc. (2898) από 2026 έως 2026
Ετήσιες καταβολές μερισμάτων
Έτος Μέρισμα (προσαρμοσμένο για διασπάσεις μετοχών) Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.
Λίστα όλων των καταβολών μερισμάτων
Έτος Μέρισμα Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.
Καταβολές μερισμάτων για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Αριθμός καταβολών μερισμάτων Χώρα
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH